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We describe a two-step strategy to alter any mouse locus repeatedly and efficiently by direct positive
selection. Using conventional targeting for the first step, a functional neo gene and a nonfunctional HPRT
minigene (the "socket") are introduced into the genome of HPRT- embryonic stem (ES) cells close to the
chosen locus, in this case the j8-globin locus. For the second step, a targeting construct (the "plug") that
recombines homologously with the integrated socket and supplies the remaining portion of the HPRT minigene
is used; this homologous recombination generates a functional HPRT gene and makes the ES cells
hypoxanthine-aminopterin-thymidine resistant. At the same time, the plug provides DNA sequences that
recombine homologously with sequences in the target locus and modifies them in the desired manner; the plug
is designed so that correctly targeted cells also lose the neo gene and become G418 sensitive. We have used two
different plugs to make alterations in the mouse 1-globin locus starting with the same socket-containing ES cell
line. One plug deleted 20 kb of DNA containing the two adult 0-globin genes. The other replaced the same
region with the human I-globin gene containing the mutation responsible for sickle cell anemia.
Gene targeting in embryonic stem (ES) cells has made
possible the construction of mice with predetermined muta-
tions, including null mutations in many genes associated with
human disease. Many genetic disorders, however, are not due
to null mutations. In fact, at many disease-associated loci, the
diversity of mutations causes a similar diversity in symptoms.
For example, different mutations in the P-globin locus cause
congenital Heinz body hemolytic anemia, familial cyanosis,
sickle cell anemia, and thalassemias varying in severity (25).
Mutational diversity consequently poses a challenge in design-
ing mouse models of human disease, since each mutation must
be targeted to the same locus as a separate recombination
event.
Conventional gene targeting involves positively selecting
cells that have incorporated exogenous DNA, which includes a
selectable marker such as the neo gene linked to sequences
homologous to the target locus, followed by screening these
transformants for cells in which the desired homologous
recombination event has occurred (21). For some recombina-
tion events, thousands of colonies may have to be screened to
find those that are targeted (10, 19), although the number can
often be reduced by adding a negatively selectable marker such
as the herpes simplex virus (HSV) tk gene to the construct (14).
Altering a gene in many different ways by these procedures
requires repeating the selection and screening for each modi-
fication. Strategies have therefore been devised to eliminate
the repeated screening (1, 22, 26). For example, Askew et al.
(1) used a two-step method to repeatedly modify the cx2-Na,K-
ATPase gene. In the first step, both the neo and HSV tk genes
were inserted into the target locus by conventional gene
targeting. In the second step, the target gene was modified by
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a second targeting event using a construct designed to intro-
duce a mutation while simultaneously removing the HSV tk
gene. This second targeting step theoretically requires only
negative selection against the inserted marker, which can be
repeated easily. In practice, however, the second step may
involve more screening than the first because of a high
background of nontargeted cells that spontaneously lose ex-
pression of the negatively selectable marker. Loss of marker
function can occur (i) by recombination, (ii) by inactivation
(e.g., methylation or mutation), or (iii) by nondisjunction. The
incidence of background colonies therefore depends upon the
number of cell divisions taking place between any type of
spontaneous loss of the marker function and the loss of marker
function due to the second targeting event. Unless a selection
scheme is used to avoid their survival, background mutants will
consequently accumulate during the cell expansion between
the two targeting events. If spontaneous loss of the marker
function occurs in a cell 10 generations prior to the second
targeting, this one event will result in 1,024 (210) background
colonies. If the loss occurs three generations prior to the
second targeting, there will be 8 (23) background colonies. This
phenomenon was first described by Luria and Delbruck in
1943, who termed it fluctuation, since it causes the number of
background colonies to fluctuate widely from experiment to
experiment (12). Strategies relying on negative selection for
loss of function in ES cells are therefore likely to exhibit wide
fluctuations in the numbers of background colonies.
We have devised a two-step targeting strategy that elimi-
nates the problems associated with background colonies. Un-
planned losses of marker function and fluctuation problems
are both avoided by using positive rather than negative selec-
tion for the second step and by designing the system so that the
positively selectable marker cannot spontaneously become
functional. The first step in our "plug and socket" strategy uses
conventional targeting to introduce a nonfunctional portion of
the selectable marker (the "socket") close to the chosen locus.
6936
Vol. 14, No. 10
REPEATED TARGETING OF THE P-GLOBIN LOCUS 6937
The second step modifies the locus by homologous recombi-
nation with a targeting construct (the "plug") designed to have
two functions. First, the plug modifies the target gene in the
desired manner. Second, the plug recombines with the non-
functional marker and converts it into a functional form. The
plug and the socket are designed to contain different nonre-
vertible mutations (deletions) in the marker gene. Conse-
quently restoration of function is absolutely dependent upon
homologous recombination. Furthermore, since the plug and
socket steps are independent, one ES cell line with an appro-
priate socket can be transformed repeatedly with a variety of
plugs using direct positive selection.
We here describe using the plug and socket system to
repeatedly modify the mouse ,B-globin locus. First, an ES cell
line was made by targeting a socket to the 3-globin locus. Two
different plugs were then used to make two different modifi-
cations in the same socket-containing cell line. The first plug
deleted a 20-kb portion of mouse chromosome 7 containing
the two adult ,-globin genes. The second plug replaced this
region with the human ,-globin variant responsible for sickle
cell anemia (3S).
MATERMILS AND METHODS
Cloning and plasmids. A conventional targeting construct,
AIC, contains a 0.8-kb HindIII-BamHI fragment that includes
exon 1 of the 13maj gene and a 3.9-kb HindIII fragment from
downstream of the r3mln gene, with both fragments being from
BALB/c mouse DNA. The mouse DNA fragments were
flanked by two HSV tk genes (14) and were separated by the
neo gene (a 1.1-kb fragment of pMClNeopA [24]).
The socket targeting construct, ,socket (see Fig. 2), was
made from DNA isolated from the ES cell strain E14TG2a by
screening a phage genomic fragment library (made by partial
digestion with Sau3A) with a probe for I3mlf. Two fragments
were inserted into the 8.0-kb fragment of ES cell DNA at a
unique BglII site downstream of the I,min gene. The first
fragment was an XhoI-SalI fragment from pMClNeopA (24);
it was inserted in a transcriptional orientation opposite to that
of pmin. The second fragment was inserted downstream of the
neo gene in the same orientation as ,Bmin; it contains a portion
of a human HPRT minigene referred to below as AHPRT.
AHPRT is a 7.6-kb BamHI fragment from pNIlAc,2 (16); it
lacks a promoter and exon 1.
Two 3-globin deletion plugs were made. One, ,BAplug6.9,
has 6.9 kb of plug-socket overlap in the HPRT minigene. It
consists of (i) a 1.6-kb BamHI-HindIII fragment from up-
stream of the BALB/c 1mai gene; (ii) a 1.2-kb BglII-HindIII
fragment from downstream of the BALB/c p,in gene (this
fragment is not relevant to the experiments described here);
and (iii) a 7.4-kb ClaI-Hindlll portion of the human HPRT
minigene, referred to below as HPRTA6.9, which contains the
promoter, exons 1 and 2 of the HPRT minigene, and 6.9 kb of
overlap with AHPRT. All three fragments are in the same
transcriptional orientation.
The other ,B-globin deletion plug, PAplugl.5 (see Fig. 4), has
1.5 kb of plug-socket overlap in the HPRT minigene. It consists
of (i) a 3.9-kb BamHI-HindIII fragment from just upstream of
the BALB/c '3maj gene and (ii) a 1.9-kb ClaI-XhoI fragment,
referred to below as HPRTA1.5, containing the promoter and
exon 1 of the HPRT minigene from pNI1,2 (16). All three
fragments are in the same transcriptional orientation.
A ,B-globin replacement plug, Psplugl.5 (see Fig. 6), was
derived from PAplugl.5 by inserting a 5.7-kb HindIII-XbaI
fragment of human PS globin DNA just upstream of the
HPRTA1.5 fragment and in the same transcriptional orienta-
tion.
Cell culture and electroporation. Electroporations were
performed on the HPRT-deficient embryonic stem cell line
E14TG2a (8). In one case, we used a subclone designated BK4
which was obtained by dilution cloning from the strain
E14TG2a (a gift from Beverly H. Koller, University of North
Carolina at Chapel Hill). These cell lines were maintained on
irradiated mouse embryonic fibroblasts as described previously
(10).
Linearized targeting constructs were introduced into ES
cells in a 5-mm-long, 100-mm2 cross-section chamber by
electroporation with a 250-,uF capacitor charged to 300 V; 2 x
107 to 4 x 107 cells were electroporated with DNA at a 4 to 5
nM concentration. The constructs PAC, I3Aplug6.9, Psocket,
PAplugl.5, and PSplugl.5 were linearized with SacII, NotI,
NotI, XbaI, and XbaI, respectively. The P3AC construct was
introduced into E14TG2a cells, and the Isocket construct was
introduced into the BK4 subclone of E14TG2a. The plug
constructs were introduced into cell line B20 (see below) which
contains an appropriately targeted socket. B20 was expanded
and preserved by freezing to provide cells for many targeting
electroporations and for tests of its capability of contributing to
the mouse germ line.
Preparation and analysis of genomic DNA. PCR was used to
screen for targeting of PAC as described previously (9, 18).
DNA for Southern analyses was extracted from ES cells grown
in 24-well plates without feeder layer cells. Five probes were
used in Southern analyses. The P1.2 probe (see Fig. 2) was
made by PCR with genomic DNA from a strain 129/SvJ mouse
as the template and primers 5' AACCCAGGAGGTGCCC
ATCA 3' and 5' CCAGATlTlGTGAGCTCAGGG 3'. The
NEO probe (see Fig. 2) was made by isolation of a 1.1-kb
XhoI-SalI fragment from pMClNeopA (24). The HPRT 0.3
(see Fig. 2) and HPRT 0.5 (see Fig. 4) probes are, respectively,
a 0.3-kb XhoI-HindIII fragment and a 0.5-kb ClaI-BamHI
fragment from pNIlAc,2 (16). The PIVS2 probe (see Fig. 6) is
a human-specific ,-globin probe described previously (19); it is
a 920-bp BamHI-EcoRI fragment from the second intron of
human P-globin.
RESULTS AND DISCUSSION
Plug and socket strategy. The general scheme for the plug
and socket strategy is illustrated in Fig. 1. In the first step of
this two-step procedure, conventional gene targeting is used to
insert a construct that we call a socket near the gene to be
altered. A socket consists of a functional positively selectable
marker (Ml) and a nonfunctional portion of a different
positively selectable marker (AM2). ES cell clones made drug
resistant by Ml are screened by Southern analysis or PCR to
identify clones containing the correctly targeted socket. A few
of these clones are expanded to provide cells for repeated
targeting with many different constructs. In the second step of
the procedure, a vector that we call a plug alters the locus
containing the socket and supplies the missing portion of the
positively selectable marker M2. To accomplish this, the plug
contains mouse DNA sequences from the gene to be altered
and a nonfunctional portion of the second marker (M2A)
which overlaps AM2. Recombination between AM2 and M2A,
mediated by their shared homology, reconstructs a functional
M2. The two positively selectable markers, 1 and 2, must be
different (for example, hyg and neo or neo and HPRT) but are
otherwise not constrained. The two nonfunctional versions of
M2, M2A and AM2, should have nonrevertible but comple-
mentary mutations, preferably deletions. Since the plug and
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restriction fragment diagnostic of correct targeting. Figure 3A
shows data from eight of the G418-resistant clones; clone 1 has
the 10.3-kb band expected from a correctly targeted cell. The
other two bands, at 15 and 7.3 kb, are from the other adult
13-globin genes in the ES cell genome that are not modified by
AM2 \ the targeting event. The frequency of gene targeting for theintroduction of the socket is shown in Table 1.
One of the putatively targeted ES cell lines, B20, was
analyzed further to confirm correct insertion of the socket.
Step 1: select for Ml Southern analysis of B20 with the NEO probe in Fig. 3B shows
the expected fragment sizes for the correctly modified locus.
Ml AM2 The two bands of unequal intensity in the EcoRI lane are
expected since the neo gene contains an EcoRI site producing
a 13.5-kb and a 10.3-kb fragment with differing amounts of
homology to the probe (0.17 kb versus 1.0 kb, respectively).
l / Z / Further confirmation of B20 by Southern analysis with the
/ zl / probe HPRT 0.3 is shown in Fig. 3C; this probe was derived
lM2 from the exons 3 to 6 of human cDNA and has homology to the
HPRT minigene as well as to the mouse Hprt gene. The first
five lanes of Fig. 3C show that B20 has the expected fragment
sizes for a correctly targeted socket. For comparison, the last
Step 2: select for M2 and five lanes of Fig. 3C show the fragments resulting from various
screen for loss of Ml digests of unmodified ES cell DNA; these fragments contain
exon 3 of the X-linked mouse Hprt gene (15) which has 170 bp
M2 of homology to the HPRT 0.3 probe. Fragments correspondingto exons 4 to 6 have less than 80 bp of homology to the probe
and are not seen. The expected fragment sizes for the mouse
Hprt gene with XbaI and EcoRI are 2.2 and 1.3 kb, respectively,
ng the plug and socket strategy. which were too small to be included in Fig. 3C.
:ross-hatched box, and the two Proof of the germ line competence of socket ES cells. Since
stippled boxes. The first step one of our goals for using the plug and socket strategy is to
Feting construct containing a introduce specific mutations into mice, we investigated the
lifferent nonfunctional marker ability of B20 to contribute to the mouse germ line. Whenever
ie target area. Homologies are animals are to be derived, testing the germ line competence of
ith each crossover shown asan.. 'requiressovelectiownfM and a socket-containing ES cell is clearly valuable prior to its use
pne containing the socket at the for the second step of introducing plugs. Tests showed that cell
ihe completion of the nonfunc- line B20 has a normal number of chromosomes, and injection
veen the socket in the ES cell of the cells into blastocysts yielded chimeras at a normal
-t. The plug contains homology frequency. One of four chimeras transmitted the ES cell
inctional portion of M2 (M2A) genome to its progeny. These tests consequently establish that
ye is represented by an asterisk. the B20 cell line is still pluripotent.
a functional M2 and screening Deletion of the adult I-globin genes. The presence of mouse
event to insert the socket. The f-globin chains affects the phenotypes of transgenic micedified in the chromosome, and
X construct. (B) Recombination expressing mutant forms of human hemoglobin (17). Although
The upper line represents the there are some mutations that lower the level of adult hemo-
the lower line represents the globin in mice (18, 20), no null mutation exists for both the
d change in the chromosome of adult 3-globin genes, pmai and I3pmI. A mouse heterozygous for
such a double null mutation would consequently be valuable
for breeding to mice harboring human 3-globin transgenes
with the aim of subsequently obtaining offspring that depend
solely on the transgene for their adult ,B-globin. Toward this
nts, different plugs can be goal, we constructed a plug that can delete both the ,rmaJ and
Is starting with the same cell I3min genes. This deletion plug, ,3Aplugl.5 (Fig. 4), contains 4
ly targeted socket. kb of homology upstream of 1'aJ and 1.5 kb of homology to
e mouse 0-globin locus. We the socket sequences located downstream of the locus. The
)bin locus to test the plug desired fl-type (replacement-type) recombination event shown
uable ES cell mutants. The in Fig. 4 deletes 20 kb of the ES cell genome (containing the
et (Fig. 2), was electropo- ,3aj,r3rifl and neo genes) while completing the HPRT mini-
E14TG2a cells which lack gene.
of part of the endogenous PAplugl.5 was linearized and introduced into the socket-
ct is the neo gene; AM2 is containing ES cell line B20 in five separate electroporations.
e (see Materials and Meth- Six hypoxanthine-aminopterin-thymidine (HAT)-resistant col-
es containing the neo gene, onies were obtained. These colonies were expanded, and
-rations in their restriction Southern analysis was performed (Fig. 5). In Fig. 5A we show
ysis. Probe 31.2, which has XbaI fragments hybridizing to the HPRT 0.5 probe; this probe
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FIG. 2. Target locus, socket-containing targeting construct (psocket), and the chromosome resulting from insertion of the socket downstream
of the ,-globin locus. Representations are as in Fig. 1, with the following additions. The stippled box represents the neo gene, thick lines indicate
HPRT introns, and black boxes represent HPRT exons. Relevant restriction sites for BamHI (B), BglII (Bg), EcoRI (E), HindIII (H), and XbaI
(X) are shown. Various probes are shown as open boxes.
minigene (Fig. 4). Lane S of Fig. 5A shows an 8.9-kb XbaI
fragment containing the neo gene in DNA from the B20
socket-containing ES cells. The next six lanes (AP1 to AP6)
contain digests of DNA isolated from the six HAT-resistant
colonies following introduction of the deletion plug. One of
these clones (AP1) gives a 13-kb XbaI fragment (Fig. 5A) that
corresponds to the desired deletion. This same clone also gives
a 12.4-kb HpaI fragment (Fig. 5B) that is likewise diagnostic of
the desired targeting event. The other five colonies were
correctly targeted to the HPRT portion of the socket-contain-
ing ,-globin locus but not to the portion of the locus upstream
of the 'maj gene, as discussed below in relation to alternate
recombination pathways. Distinction between the two types of
targeted clone is readily made by testing the HAT-resistant
colonies for G418 resistance: correctly targeted colonies are
resistant to HAT but sensitive to G418, and incorrectly tar-
geted clones are resistant to both selective agents. A compila-
tion of data from these electroporations is provided in Table 1.
Replacement of the adult mouse genes with human PAs.
Toward the goal of correctly expressing a targeted human
,B-globin variant in a mouse, we constructed a plug targeting
vector, 3splugl.5, containing the human 13S gene. As shown in
Fig. 6, the 3Splugl.5 vector is designed to replace the 1'maj,
,B,l and neo genes with a 5.7-kb HindIII-XbaI fragment
containing the human ps-globin gene. Psplugl.5 also has two
features designed to ensure that the human Ps gene will
express correctly. First, to avoid promoter competition (2), the
plug deletes all known regulatory sequences for both P3naj and
pmin, with the exception of the mouse locus control region (4,
5, 13). Second, the plug contains human ,3S gene sequences
already known to express correctly in transgenic mice (2).
Three electroporations with Psplugl.5 yielded two HAT-
resistant colonies. One of them was sensitive to G418 and was
therefore expected to be correctly targeted; the other was
resistant and was expected to be incorrectly targeted. Southern
blot analyses of these colonies, illustrated in the last two lanes
of Fig. 5A and in Fig. SC, confirm these expectations. The
HAT-resistant, G418-sensitive clone 13SP2 has a 19-kb XbaI
A) R1.2 probe
kb 1 2 3 4 5 6 7 8
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FIG. 3. Southern blot analysis to detect correct insertion of the
socket downstream of the mouse ,B-globin locus. Probes, expected
fragment sizes, and abbreviations are as for Fig. 2. (A) Southern blots
using the probe P1.2 with EcoRI digests of DNA from G418-resistant
ES cell clones after introduction of the socket targeting construct,
Isocket. (B) Southern blots using the NEO probe with various digests
of B20 ES cell DNA. (C) Southern blots using the HPRT 0.3 probe
with various digests of DNA from clone B20 (first five lanes) and from
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TABLE 1. Targeting frequency data
No. of clones Total homology Total targeting Qi-type frequency
Total no. of targeted (kb) frequencyNo. of No. of No.ofTargeting cells electro- PerfPer
construct electro- resistant clones Per Per HAP'
porations porated colonies screened fl type 0 type fl type 0 type Per cell colony Per cell resistant G418s colony
PAC 5 10 893a 600b 0 NAc 4.7 NA 0 0 0 0 NAW
l3socket 2 6 1,035d 189 17 NA 8.0 NA 1.5 x 10-6 9.0 1.5 X 10-6 9.0 NA
flAplugl.5 5 15 6e 6 1 4 5.5 1.5 3.3 x 108 83 6.6 x 109 17 100
f3Aplug6.9 2 6 40e 38 0 38 8.5 8.1 6.7 x 10-7 100 0 0 NDf
P3plugl.5 3 9 2e 2 1 1 5.5 1.5 2.2 x 10-8 100 1.1 x 10- 50 100
a G418 and ganciclovir selection.
6 Equivalent to 6,000 colonies resistant to G418 alone.
c NA, not applicable.
d G418 selection.
e HAT selection.
f ND, not determined.
fragment hybridizing to the HPRT 0.5 probe and a 10-kb NdeI
fragment hybridizing to the human-specific ,BIVS2 probe; these
fragments are of the sizes expected for the correct replacement
targeting (Fig. 6). The HAT-resistant, G418-resistant colony
does not give fragments of the expected sizes and is therefore
incorrectly targeted, and we show below that it is the result of
a complex event. A compilation of data from electroporations
with ISplugl.5 is presented in Table 1.
Alternate recombination pathways. As described above,
electroporations with the various plugs produced HAT-resis-
tant colonies that were of two types. The desired colonies are
HAT resistant and G418 sensitive; the undesired colonies are
HAT resistant and G418 resistant. The nature of the undesired
event was deduced from the following data, which also allowed
us to design plug vectors yielding a higher proportion of
desirable products.
Five of the six HAT-resistant colonies obtained with
P3SIplugl.5 gave results from Southern blots that were not
consistent with the desired fl-type recombinational event. For
example, Fig. 5A shows that clones AP3 and AP5 have two
XbaI bands (7.6 and 10 kb) instead of the expected 13-kb band.
These fragments are, however, readily interpreted as being the
consequence of an 0-type (insertion-type) recombinational
event in which the plug construct first recircularized and then
recombined as shown in Fig. 7. Clones zNP4 and AP6 show only
one XbaI band, at 17 kb, indicating that loss of the XbaI site in
the plug construct had occurred prior to recombining in an
0-type reaction. Southern analysis with other restriction di-
gests supports the view that AP3 through AP6 are products of
0-type reactions (data not shown). One clone (AP2) showed
no change in the size of the XbaI fragment from the socket
downstream of 3-globin. This clone had, however, an addi-
tional BamHI fragment, indicating that the X-linked mouse
Hprt locus was now wild type (data not shown). We suspect
that this clone AP2 resulted from the acquisition of mouse Hprt






























FIG. 4. The socket-containing chromosome, the linearized plug targeting construct for deletion, and the chromosome obtained after deletion.
Representations are as in Fig. 2, with the following additions: (i) the thick broken line of the targeting construct represents plasmid sequences, and
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FIG. 5. Southern blot analysis of HAT-resistant ES cell clones after
introduction of plugs. (A) Southern blot with the probe HPRT 0.5 of
XbaI-digested DNA. Lane S was with DNA from the socket ES cell
line B20. Lanes AP1 (deletion plug clone 1) through AP6 contain DNA
from six HAT-resistant ES cell lines isolated after introduction of
PAplugl.5; the expected sizes and probes are shown in Fig. 4. Lanes
labeled Ps (1S plug) represent two ES cell lines derived after
introduction of psplugl.5; the expected sizes and probes are shown in
Fig. 6. (B) Southern blot using the probe HPRT 0.5 with HpaI-digested
DNA from S (socket cell line B20) and AP1 (HAT-resistant clone 1
derived from introduction of the f3Aplugl.5). (C) Southern blot using
the probe PIVS2 with NdeI-digested DNA from two HAT-resistant ES
cell lines (1 and 2) from introduction of 3splugl.5; the expected sizes
and probes are shown in Fig. 6.
feeder layer cells present during electroporation of the plug,
although the Southern blots showed no evidence that the Hprt
deletion on the X chromosome in AP2 (or in any of the other
clones) had been corrected by the plug.
Electroporation of osplugl.5, as described above, gave one
HAT-resistant colony (PSP1) which was not the desired fl-type
event. Southern blot analysis of DNA from this colony re-
vealed an 8.9-kb and a 16.9-kb XbaI band (Fig. 5). These bands
could be the result of two independent events: (i) a spontane-
ous recombination event resulting in both homologs of chro-
mosome 7 having a socket and (ii) the insertion of a portion of
the plug targeting construct (after a 6.9-kb deletion that
removed the XbaI linearization site) to one of the two sockets
via an 0-type recombinational event.
The foregoing analyses indicate that 0-type crossing over
within the AHPRT portion of the target locus can occur
without crossing over in the P-globin portion. We reasoned,
therefore, that use of a relatively short stretch of homology
between HPRTA and AHPRT should reduce the chances of this
type of event, since the initial targeting would likely be
mediated by the much longer stretch of homology in the
3-globin portion. This argument receives considerable support
from our observation (Table 1) that a plug (A43plug6.9) with a
6.9-kb stretch of HPRT overlap gave approximately 30 times
more of the 0-type events than were seen with the 1.5-kb
stretch of overlap. In general, therefore, it is better to drive the
second event step in the plug and socket system with large
amounts of upstream homology while limiting the HPRT
overlap. Further studies are needed to find the optimal length,
which may be less than the 1.5 kb currently used. In any case,
the proportion of desired colonies is so high (two of seven in
the experiments with 1.5 kb of overlap) that a simple screen for
sensitivity to G418 can be used to eliminate the unwanted
0-type events.
Overall frequencies of gene targeting. Table 1 summarizes
the data obtained with several different targeting constructs.
These data show that of the 46 HAT-resistant colonies ana-
lyzed from three plug constructs (PAplugl.5, 3Aplug6.9, and
3splugl.5), 45 colonies were targeted. The one colony that was
an exception was probably the result of the transfer of an Hprt
gene from the feeder layer to the ES cell during electropora-
tion. Therefore, for all practical purposes, the plug and socket
method has eliminated background colonies which were not
the result of gene targeting. However, there are two types of
targeting event that result from the introduction of a plug. One
of these is the desired fl-type event, and the other is the
undesired 0-type event. This background of undesired events
can be reduced substantially by reducing the amount ofHPRT
homology in the plug, and this background is eliminated by
neo v


















FIG. 6. The socket-containing chromosome, the linearized plug targeting construct for insertion of human 13S globin, and the chromosome
obtained after insertion. Representations are as in Fig. 2, with the following additions: (i) the thick broken line of the targeting construct represents
plasmid sequences; and (ii) N and X represent NdeI and XbaI restriction sites, respectively.
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FIG. 7. The socket-containing chromosome, the recircularized PAplugl.5 targeting construct, and the chromosome after an 0-type
recombination. The recircularized PAplugl.5 inserts into the socket ES cell genome by a single crossover within the HPRT sequences. The resulting
chromosome contains all original socket chromosome sequences as well as the sequences of the plug targeting construct, thus creating a duplication
of a portion of the HPRT sequences as well as a functional HPRT gene. Symbols are described in the legend to Fig. 2.
screening for G418 sensitivity. Thus, the two plugs with 1.5 kb
of HPRT homology (r3Aplugl.5 and ,BSplugl.5) yielded seven
HAT-resistant colonies, of which two were G418 sensitive;
both of these colonies were the desired fl-type events.
We have also included in Table 1, for comparison, data
obtained from a conventional targeting construct, PAC. This
construct has the neo gene between a 0.8-kb region of homol-
ogy 5' to the 13maJ gene and a 3.9-kb region of homology 3' to
the p,mln gene. Although this homology differs from that used
in ,BAplugl.5 (3.9 kb of homology 5' to 13maj and 1.5 kb with the
incomplete HPRT minigene 3' to 13min), these constructs have
many similarities, including the following: (i) both have the
potential to delete approximately 20 kb including both adult
,-globin genes, (ii) the origin of the homology for both
constructs was BALB/c DNA, and (iii) the lengths of homology
were similar (4.7 kb for PAC and 5.5 kb for the two plugs).
However, screening the equivalent of 6,000 G418-resistant
clones by PCR failed to yield any targeted colonies with PAC.
Thus, we estimate that screening is reduced more than 1,000-
fold by use of the plug and socket strategy.
Frequencies of gene targeting per cell electroporated vary
depending on many factors. A typical frequency for a conven-
tional gene targeting experiment is approximately one targeted
cell per 2 million electroporated cells (3). The two plugs
PAplugl.5 and PSplugl.5 targeted at an approximately 17-fold-
lower frequency (one targeted cell per 34 million cells),
possibly as a result of the use in the targeting constructs of
DNA from a strain of mouse not isogenic to the ES cell strain
(6, 7, 23). Yet despite this lower rate of targeting per cell, the
positive selection inherent to the plug and socket procedure
allowed us to recover the desired events with minimal effort.
This ability to isolate correctly targeted cells even with vectors
not maximized for their efficiency emphasizes the power of
using a recombination-dependent positive selection for the
second step. It is this use of a recombination-dependent
positive selection that distinguishes our present system from
repeated targeting strategies previously reported (1, 22, 26).
Limitations of the procedure. The major limitation of the
plug and socket procedure is that the positively selectable
marker (the HPRT minigene) remains near the target locus at
the end of the experiment. The degree to which this is
important will vary in different instances, but the effects of the
residual marker can always be ascertained, if this is necessary,
by carrying out a control targeting experiment with a plug that
causes no changes in the target locus itself. The product of this
control experiment (a plug and socket next to the wild-type
locus) will provide a baseline against which all the other
mutations can be evaluated.
Comparison with other repeated targeting strategies. Sev-
eral other two-step strategies for repeated targeting have been
described. All rely on negative selection to isolate clones that
have lost a marker (1, 22, 26). Briefly, these procedures use
conventional gene targeting to introduce a negatively select-
able marker to a specific location in the genome as a first step.
In the second step, a different gene targeting construct is used
to introduce a mutation to the same site while simultaneously
removing the negatively selectable marker. Selection against
this marker is used to isolate the targeted clones. Since the loss
of marker function can occur by events other than homologous
recombination, these strategies generally give a background of
resistant clones that are not targeted. Nevertheless, these
methods have the advantage of not leaving any marker se-
quence at the targeted locus once they are completed and can
therefore be used at any position within the locus. The ratio
between the loss of the selectable marker by nontargeted
events to its loss by homologous recombination determines
whether the desired recombinants will be recoverable from the
background of untargeted clones.
Other applications. In general, the procedure that we have
described is most useful for carrying out series of experiments
in which a target locus is to be modified systematically. The
ease with which we achieved two large changes at the mouse
P-globin locus exemplifies one such application. Another series
might include a variety of small mutations in the promoter of
a target gene, with the caveat that the mutants would have to
be compared against a control in which the wild-type gene and
promoter had the reconstituted HPRT minigene upstream.
Possible alterations. We described above how differentiat-
ing between 0- and fl-type recombination events can be
achieved simply by a screen for G418 sensitivity. This genetic
screen could readily be changed to genetic selection. For
example, the HSV tk gene could be introduced into the plug
construct outside the region of homology. The fl-type recom-
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ganciclovir, whereas the 0-type recombinants would retain the
HSV tk gene as a consequence of recircularization and would
be sensitive to ganciclovir (14).
We chose the HPRT gene as the second selectable marker in
our present applications of the plug and socket strategy
because HAT selection is rapid and efficient. In addition,
subsequent removal of the HPRT gene can be accomplished, if
necessary, by a third gene targeting event using 6-thioguanine
selection. A disadvantage of using the HPRT gene is that the
parent ES cell line must be HPRT deficient. Other markers
might be used in its place. For example, the Aneo and neoA
gene pair devised by Kucherlapati et al. (11) would be a good
candidate for an alternate second marker with the hyg gene as
the first marker.
Future work Mice generated now or in the future from all
three ES cell lines made in the present experiments should
prove useful for other studies. Animals already generated from
the B20 ES line carry the AHPRT socket, which will make them
useful for future tests of targeting the ,-globin locus in bone
marrow stem cells by using HAT selection. Animals generated
from the ES cells having deletion of the 13maj and ,minl genes
could be mated with mice transgenic for the human P3s gene to
derive better mouse models of sickle cell anemia. Animals
generated from the ES cells having the human Ps gene in place
of the two mouse adult ,-globin genes could be mated with
comparable mice expressing human a-globin genes to derive a
mouse model of sickle cell anemia in which no adult mouse
hemoglobins are present.
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